Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
作者信息
Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S
机构信息
University of Calgary, Calgary, Canada.
Alberta Health Services, Calgary, Canada.
出版信息
J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020. Epub 2016 Dec 15.
PMID:28042931
Abstract
摘要
Zotero 插件